DOCSLIB.ORG

Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS of DEOXYADENOSINE and DEOXYGUANOSINE on DNA SYNTHESIS in HUMAN T LYMPHOBLASTS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS of DEOXYADENOSINE and DEOXYGUANOSINE on DNA SYNTHESIS in HUMAN T LYMPHOBLASTS Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA SYNTHESIS IN HUMAN T LYMPHOBLASTS James M. Wilson, … , Peter E. Daddona, William N. Kelley J Clin Invest. 1979;64(5):1475-1484. https://doi.org/10.1172/JCI109606. Deoxyadenosine and deoxyguanosine are toxic to human lymphoid cells in culture and have been implicated in the pathogenesis of the immunodeficiency states associated with adenosine deaminase and purine nucleoside phosphorylase deficiency, respectively. We have studied the relative incorporation of several labeled nucleosides into DNA and into nucleotide pools to further elucidate the mechanism of deoxyribonucleoside toxicity. In the presence of an inhibitor of adenosine deaminase [erythro-9-(2-hydroxy-3-nonyl)adenine [EHNA], 5 μM], deoxyadenosine (1-50 μM) progressively decreased the incorporation of thymidine, uridine, and deoxyuridine into DNA, but did not affect uridine incorporation into RNA. This decrease in DNA synthesis was associated with increasing dATP and decreasing dCTP pools. Likewise, incubation of cells with deoxyguanosine caused an elevation of dGTP, depletion of dCTP, and inhibition of DNA synthesis. To test the hypothesis that dATP and dGTP accumulation inhibit DNA synthesis by inhibiting the enzyme ribonucleotide reductase, simultaneous rates of incorporation of [3H]uridine and [14C]thymidine into DNA were measured in the presence of deoxyadenosine plus EHNA or deoxyguanosine, and in the presence of hydroxyurea, a known inhibitor of ribonucleotide reductase. Hydroxyurea (100 μM) and deoxyguanosine (10 μM) decreased the incorporation of [3H]uridine but not of [14C]thymidine into DNA; both compounds also substantially increased 3[ H]cytidine incorporation into the ribonucleotide pool while reducing incorporation into the deoxyribonucleotide pool. In contrast, deoxyadenosine plus EHNA did not show this […] Find the latest version: https://jci.me/109606/pdf Purinogenic Immunodeficiency Diseases DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA SYNTHESIS IN HUMAN T LYMPHOBLASTS JAMES M. WILSON, BEVERLY S. MITCHELL, PETER E. DADDONA, and WILLiAM N. KELLEY, Departments of Internal Medicine and Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109 A B S T RA C T Deoxyadenosine and deoxyguanosine reducing incorporation into the deoxyribonucleotide are toxic to human lymphoid cells in culture and have pool. In contrast, deoxyadenosine plus EHNA did not been implicated in the pathogenesis of the immuno- show this differential inhibition of [3H]uridine incor- deficiency states associated with adenosine deaminase poration into DNA, and the alteration in [3H]cytidine and purine nucleoside phosphorylase deficiency, re- incorporation into nucleotide pools was less impressive. spectively. We have studied the relative incorporation These data show an association between accumu- of several labeled nucleosides into DNA and into nu- lation of dATP or dGTP and a primary inhibition of cleotide pools to further elucidate the mechanism of DNA synthesis, and they provide support for ribonu- deoxyribonucleoside toxicity. In the presence of an cleotide reductase inhibition as the mechanism re- inhibitor of adenosine deaminase [erythro-9-(2-hydroxy- sponsible for deoxyguanosine toxicity. Deoxyadeno- 3-nonyl)adenine [EHNA], 5 ,uM], deoxyadenosine sine toxicity, however, appears to result from another, (1-50 ,utM) progressively decreased the incorporation or perhaps a combination of, molecular event(s). of thymidine, uridine, and deoxyuridine into DNA, but did not affect uridine incorporation into RNA. This INTRODUCTION decrease in DNA synthesis was associated with increasing dATP and decreasing dCTP pools. Likewise, The association of at least two inborn errors of purine incubation of cells with deoxyguanosine caused an metabolism with immunodeficiency diseases has made elevation of dGTP, depletion of dCTP, and inhibition possible the investigation of these diseases at the of DNA synthesis. molecular level. Adenosine deaminase (ADA)' defi- To test the hypothesis that dATP and dGTP accumu- ciency results in severe combined immunodeficiency lation inhibit DNA synthesis by inhibiting the enzyme disease with impairment of T- and B-lymphocyte ribonucleotide reductase, simultaneous rates of in- function (1). Purine nucleoside phosphorylase (PNP) corporation of [3H]uridine and [14C]thymidine into deficiency has been associated with T-lymphocyte DNA were measured in the presence of deoxyaden- dysfunction in nine patients (2-9). The mechanism(s) osine plus EHNA or deoxyguanosine, and in the whereby these enzyme deficiency states affect lympho- presence of hydroxyurea, a known inhibitor of ribo- cyte development and/or function has not been fully nucleotide reductase. Hydroxyurea (100 ,tM) and elucidated. However, the recent findings of markedly deoxyguanosine (10 ,M) decreased the incorporation elevated dATP levels in ADA-deficient erythrocytes of [3H]uridine but not of [14C]thymidine into DNA; both (10, 11) and of dGTP levels in PNP-deficient erythro- compounds also substantially increased [3H]cytidine cytes (12) in conjunction with high-circulating or urinary incorporation into the ribonucleotide pool while levels of the corresponding deoxyribonucleoside in these patients (3, 13) provide support for the hypothesis that deoxyribonucleosides play an important role in the J. M. Wilson is a National Science Foundation Predoctoral Fellow. Dr. Mitchell is the recipient of National Institutes of Health Clinical Investigator Award 1 K08 AM 00442. ' Abbreviations used in this paper: ADA, adenosine Received for publication 17 January 1979 and in revised deaminase; EHNA, erythro-9-(2-hydroxy-3-nonyl)adenine; form 23 July 1979. PCA, perchloric acid; PNP, purine nucleoside phosphorylase. J. Clin. Invest. (© The American Society for Clinical Investigation, Inc. 0021-9738/79111/1475/10 $1.00 1475 Volume 64 November 1979 1475-1484 pathogenesis of the immune dysfunction in these two deoxyribonucleosides into DNA, into RNA, and into diseases and suggest that deoxyribonucleosides or their ribonucleotide pools to assess the effects of deoxya- metabolites may be toxic to lymphoid cells. denosine and deoxyguanosine on ribonucleotide re- The purine deoxyribonucleosides have indeed ductase activity. Whereas our results provide more been shown to have lymphocytotoxic effects in vitro. direct evidence for the inhibition of ribonucleotide Deoxyadenosine in the presence of an inhibitor ofADA reductase in deoxyguanosine toxicity, they also suggest inhibits [3H]thymidine incorporation into DNA by that additional factors may play a role in the toxicity peripheral blood lymphocytes (14) and is toxic in micro- of deoxyadenosine. molar concentrations to a variety of mouse (15, 16) and human (17, 18) lymphoid cell lines. Deoxyguanosine METHODS in the absence of a PNP inhibitor is likewise extremely toxic to cells in culture (18-20). In addition, Radioisotopes and chemicals. [3H]Cytidine (28.0 Ci/ lymphoid mmol), [3H]uridine (24.2 Ci/mmol), [3H]deoxyuridine (21.9 the rather striking selectivity of both deoxyadenosine Ci/mmol), [3H]dTTP (18.3 Ci/mmol), and [3H]dCTP (22.3 and deoxyguanosine toxicity for human lymphoblasts Ci/mmol) were obtained from New England Nuclear (Boston, of T-cell origin, as opposed to B-cell origin (18, 21), has Mass.), and [U-_4C]thymidine (515 mCi/mmol) and [U-'4C]- provided a potential explanation for the prominent deoxycytidine (462 mCi/mmol) were obtained from Amersham Corp (Arlington Heights, Ill.). All unlabeled ribonucleosides T-cell dysfunction in patients with ADA and PNP defi- and deoxyribonucleosides, Micrococcus lysodeikticus DNA ciency, respectively. polymerase, calf thymus DNA, and Dowex 50 x 4 200-400 The cytotoxic effects of deoxyadenosine and deoxy- (Dow Chemical Co., Midland, Mich.) were purchased from guanosine on cultured cells correlate well with an Sigma Chemical Co. (St. Louis, Mo.). Affi-Gel 601 was ob- the corresponding deoxyribonucleoside tained from Bio-Rad Laboratories (Richmond, Calif.). Erythro- accumulation of 9-(2-hydroxy-3-nonyl)adenine (EHNA) was provided by triphosphate and are also associated with a decrease in Burroughs-Wellcome Co., Research Triangle Park, N. C. the intracellular dCTP pool (15, 16, 19, 20). These ob- Cell cultures. The Molt-4 T-lymphoblast line was ob- servations, in conjunction with substantial reversal of tained from Hem Research, Inc., Rockville, md., and was toxicity in several culture systems with exogenous originally derived from a patient with acute lymphoblastic leukemia. Cultures were maintained in exponential growth in deoxycytidine (16-20), have led many investigators RPMI-1640 medium plus 10% horse serum. to suggest inhibition of the enzyme ribonucleotide Deoxyribonucleotide pool measurements. Cells were reductase by dATP or dGTP as the mechanism under- incubated at a concentration of 106/ml in RPMI plus 10% heat- lying cellular toxicity (10, 16, 17, 20). Ribonucleotide inactivated horse serum at 37°C for 1 h with or without ad- catalyzing the reduction of ditives. Levels of dATP, dGTP, and dTTP were determined in reductase is responsible for 1 x 106 cells; dCTP levels were determined in 1 x 107 cells. At all ribonucleoside diphosphates, and, thus, this enzyme the end of the incubation period, cold RPMI medium (5 vol) appears to be important in the control of DNA syn- was added. The cells were sedimented at 450 g for 5 min at 4°C thesis. It is subject to strong negative allosteric
Load more

Recommended publications
  • Copyright by Jeremy Daniel O'connell 2012
    Copyright by Jeremy Daniel O’Connell 2012 The Dissertation Committee for Jeremy Daniel O’Connell Certifies that this is the approved version of the following dissertation: Systemic Protein Aggregation in Stress and Aging Restructures Cytoplasmic Architecture Committee: Edward Marcotte, Supervisor Dean Appling Andrew Ellington Makkuni Jayaram Scott Stevens Systemic Protein Aggregation in Stress and Aging Restructures Cytoplasmic Architecture by Jeremy Daniel O’Connell, B.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin September 2012 Dedication Cytisus laburnum, simul vincet omnem To my dad and mom who encouraged and enabled my education with countless sacrifices, I promised this graduation would be the one we would attend, and I am truly sorry I was not swift enough to make that possible. Acknowledgements Foremost, I thank my advisor Edward Marcotte, for not just a second lease on a life in science but one in an amazing lab environment. His intellectual rigor, enduring patience, amazing work ethic, and enthusiasm for discovery were an inspiration. I thank my collaborators in this project: Gwen Stovall, Alice Zhao, Gabe Wu, and Mark Tsechansky for their comradery and support on this great adventure. I thank the talented undergraduates: Maguerite West-Driga, Ariel Royall, and Tyler McDonald who stuck with me. Each of you will soon be a better scientist than I ever will, and I hope you enjoyed and learned from our research together nearly as much as I did.
    [Show full text]
  • The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (Cad) by Phosphorylation and Protein-Protein Interactions
    THE REGULATION OF CARBAMOYL PHOSPHATE SYNTHETASE-ASPARTATE TRANSCARBAMOYLASE-DIHYDROOROTASE (CAD) BY PHOSPHORYLATION AND PROTEIN-PROTEIN INTERACTIONS Eric M. Wauson A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Pharmacology. Chapel Hill 2007 Approved by: Lee M. Graves, Ph.D. T. Kendall Harden, Ph.D. Gary L. Johnson, Ph.D. Aziz Sancar M.D., Ph.D. Beverly S. Mitchell, M.D. 2007 Eric M. Wauson ALL RIGHTS RESERVED ii ABSTRACT Eric M. Wauson: The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (CAD) by Phosphorylation and Protein-Protein Interactions (Under the direction of Lee M. Graves, Ph.D.) Pyrimidines have many important roles in cellular physiology, as they are used in the formation of DNA, RNA, phospholipids, and pyrimidine sugars. The first rate- limiting step in the de novo pyrimidine synthesis pathway is catalyzed by the carbamoyl phosphate synthetase II (CPSase II) part of the multienzymatic complex Carbamoyl phosphate synthetase, Aspartate transcarbamoylase, Dihydroorotase (CAD). CAD gene induction is highly correlated to cell proliferation. Additionally, CAD is allosterically inhibited or activated by uridine triphosphate (UTP) or phosphoribosyl pyrophosphate (PRPP), respectively. The phosphorylation of CAD by PKA and ERK has been reported to modulate the response of CAD to allosteric modulators. While there has been much speculation on the identity of CAD phosphorylation sites, no definitive identification of in vivo CAD phosphorylation sites has been performed. Therefore, we sought to determine the specific CAD residues phosphorylated by ERK and PKA in intact cells.
    [Show full text]
  • Nucleotide Metabolism
    NUCLEOTIDE METABOLISM General Overview • Structure of Nucleotides Pentoses Purines and Pyrimidines Nucleosides Nucleotides • De Novo Purine Nucleotide Synthesis PRPP synthesis 5-Phosphoribosylamine synthesis IMP synthesis Inhibitors of purine synthesis Synthesis of AMP and GMP from IMP Synthesis of NDP and NTP from NMP • Salvage pathways for purines • Degradation of purine nucleotides • Pyrimidine synthesis Carbamoyl phosphate synthesisOrotik asit sentezi • Pirimidin nükleotitlerinin yıkımı • Ribonükleotitlerin deoksiribonükleotitlere dönüşümü Basic functions of nucleotides • They are precursors of DNA and RNA. • They are the sources of activated intermediates in lipid and protein synthesis (UDP-glucose→glycogen, S-adenosylmathionine as methyl donor) • They are structural components of coenzymes (NAD(P)+, FAD, and CoA). • They act as second messengers (cAMP, cGMP). • They play important role in carrying energy (ATP, etc). • They play regulatory roles in various pathways by activating or inhibiting key enzymes. Structures of Nucleotides • Nucleotides are composed of 1) A pentose monosaccharide (ribose or deoxyribose) 2) A nitrogenous base (purine or pyrimidine) 3) One, two or three phosphate groups. Pentoses 1.Ribose 2.Deoxyribose •Deoxyribonucleotides contain deoxyribose, while ribonucleotides contain ribose. •Ribose is produced in the pentose phosphate pathway. Ribonucleotide reductase converts ribonucleoside diphosphate deoxyribonucleotide. Nucleotide structure-Base 1.Purine 2.Pyrimidine •Adenine and guanine, which take part in the structure
    [Show full text]
  • Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
    Journal of the American Heart Association ORIGINAL RESEARCH Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals Joonatan Palmu , MD; Aaro Salosensaari , MSc; Aki S. Havulinna , DSc (Tech); Susan Cheng , MD, MPH; Michael Inouye, PhD; Mohit Jain, MD, PhD; Rodolfo A. Salido , BSc; Karenina Sanders , BSc; Caitriona Brennan, BSc; Gregory C. Humphrey, BSc; Jon G. Sanders , PhD; Erkki Vartiainen , MD, PhD; Tiina Laatikainen , MD, PhD; Pekka Jousilahti, MD, PhD; Veikko Salomaa , MD, PhD; Rob Knight , PhD; Leo Lahti , DSc (Tech); Teemu J. Niiranen , MD, PhD BACKGROUND: Several small-scale animal studies have suggested that gut microbiota and blood pressure (BP) are linked. However, results from human studies remain scarce and conflicting. We wanted to elucidate the multivariable-adjusted as- sociation between gut metagenome and BP in a large, representative, well-phenotyped population sample. We performed a focused analysis to examine the previously reported inverse associations between sodium intake and Lactobacillus abun- dance and between Lactobacillus abundance and BP. METHODS AND RESULTS: We studied a population sample of 6953 Finns aged 25 to 74 years (mean age, 49.2±12.9 years; 54.9% women). The participants underwent a health examination, which included BP measurement, stool collection, and 24-hour urine sampling (N=829). Gut microbiota was analyzed using shallow shotgun metagenome sequencing. In age- and sex-adjusted models, the α (within-sample) and β (between-sample) diversities of taxonomic composition were strongly re- lated to BP indexes (P<0.001 for most). In multivariable-adjusted models, β diversity was only associated with diastolic BP (P=0.032).
    [Show full text]
  • List of Abbreviations
    List of Abbreviations 1,3BPGA 1,3-Bisphospho-D-glycerate 10-formyl THF 10-Formyltetrahydrofolate 2PG 2-phospho-D-glycerate 3PG 3-phospho-D-glycerate 3PPyr 3-phosphonooxypyruvate 3PSer 3-phosphoserine 6PDG 6-phospho-D-gluconate 6Pgl glucono-1,5-lactone-6-phosphate AcAcACP acetoacetyl-ACP AcAcCoA acetoacetyl-CoA AcACP acetyl-ACP AcCoA acetyl-CoA ACP acyl carrier protein ADP adenosine 5'-diphosphate AKG alpha-ketoglutarate Ala alanine AMP adenosine 5'-monophosphate Arg arginine ArgSuc argininosuccinate Asn asparagine Asp aspartate ATP adenosine 5'-triphosphate CDP cytidine 5'-diphosphate Chol cholesterol Ci citrulline Cit citrate CMP cytidine 5'-monophosphate CO2 carbon dioxide CoA coenzyme A CP carbamoyl-phosphate CTP cytidine 5'-triphosphate Cytc-ox ferricytochrome c Cytc-red ferrocytochrome c dADP 2'-deoxyadenosine 5'-diphosphate dAMP 2'-deoxyadenosine 5'-monophosphate dCDP 2'-deoxycytosine 5'-diphosphate dCMP 2'-deoxycytosine 5'-monophosphate dGDP 2'-deoxyguanosine 5'-diphosphate dGMP 2'-deoxyguanosine 5'-monophosphate DHAP dihydroxyacetone phosphate DHF 7,8-Dihydrofolate dTMP 2'-Deoxythymidine-5'-monophosphate dUDP 2'-Deoxyuridine-5'-diphosphate dUMP 2'-Deoxyuridine-5'-monophosphate Ery4P erythrose-4-phosphate F16BP fructose 1,6-bisphosphate F6P fructose 6-phosphate FAD flavin adenine dinucleotide FADH2 flavin adenine dinucleotide reduced for formate fPP farnesyl diphosphate Fum fumarate G6P glucose 6-phosphate GA guanidinoacetate GA3P glyceraldehyde 3-phosphate GDP guanosine 5'-diphosphate Glc glucose Gln glutamine Glu glutamate GluSA
    [Show full text]
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • Supplementary Table S1. Table 1. List of Bacterial Strains Used in This Study Suppl
    Supplementary Material Supplementary Tables: Supplementary Table S1. Table 1. List of bacterial strains used in this study Supplementary Table S2. List of plasmids used in this study Supplementary Table 3. List of primers used for mutagenesis of P. intermedia Supplementary Table 4. List of primers used for qRT-PCR analysis in P. intermedia Supplementary Table 5. List of the most highly upregulated genes in P. intermedia OxyR mutant Supplementary Table 6. List of the most highly downregulated genes in P. intermedia OxyR mutant Supplementary Table 7. List of the most highly upregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Table 8. List of the most highly downregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Figures: Supplementary Figure 1. Comparison of the genomic loci encoding OxyR in Prevotella species. Supplementary Figure 2. Distribution of SOD and glutathione peroxidase genes within the genus Prevotella. Supplementary Table S1. Bacterial strains Strain Description Source or reference P. intermedia V3147 Wild type OMA14 isolated from the (1) periodontal pocket of a Japanese patient with periodontitis V3203 OMA14 PIOMA14_I_0073(oxyR)::ermF This study E. coli XL-1 Blue Host strain for cloning Stratagene S17-1 RP-4-2-Tc::Mu aph::Tn7 recA, Smr (2) 1 Supplementary Table S2. Plasmids Plasmid Relevant property Source or reference pUC118 Takara pBSSK pNDR-Dual Clonetech pTCB Apr Tcr, E. coli-Bacteroides shuttle vector (3) plasmid pKD954 Contains the Porpyromonas gulae catalase (4)
    [Show full text]
  • Classical and Rational Approaches to Antifungal Drug Design
    Classical and rational approaches to antifungal drug design Jessica Louise Chitty BSc (Hons) A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2017 School of Chemistry and Molecular Biosciences Institute of Molecular Biosciences Abstract The emergence of human immunodeficiency virus (HIV) in the 1980s has led to an increase in infections from previously rare pathogens. Many of these now cause widespread infection among individuals with compromised immune systems, not just limited to AIDS patients but also to those placed on immunosuppressive medication. The encapsulated yeast Cryptococcus neoformans causes widespread disease in the immunocompromised population, particularly in sub-Saharan Africa where it is a major cause of AIDS-related mortality due in part to limited resources and variable drug availability. Current treatment options are restricted to three out-dated antifungals amphotericin B, flucytosine and fluconazole; where possible they are used in combination as nephrotoxicity and resistance are contributing factors in the unacceptably high mortality rates. Alternative therapeutic agents are urgently required to improve survival rates and combat antifungal drug resistance. Two main routes of compound development can be taken: classical drug screening or rational drug design. Classical design requires groups of compounds to be screened against pathogens and those identified with high efficacy and low cytotoxicity are pursued. Rational drug design requires a detailed characterization of the proposed target; exploitable differences between the pathogen and human host are sought out as potential druggable targets. In this thesis both classical and rational methods have been investigated. A classical approach was taken to investigate a class of octapeptin compounds, produced as secondary metabolites by the soil dwelling bacterium, Bacillus circulans.
    [Show full text]
  • Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide
    ICANCER RESEARCH 26 Part 1, 1466-1472,July 1966] Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic Acid Synthetase System of Sensitive and Resistant Plasmacytomas1 ARTHUR J. TOMISEK, MARTHA BRUCE IRICK, AND PAULA WEDELES ALLAN Kettering'-Meyer Laboratory,2 Southern Research Institute, Birmingham, Alabama Summary term DNA-synthetase. In addition to this measurement of over-all DNA synthetase activity, we used the same experiments We have shown that the in vivo treatment of Fortner plasma- to determine the time course of radioactivity distribution among cytomas with Cyclophosphamide can lead to strong inhibitions of both deoxyribonucleic acid nucleotidyl transferase and thymi- the soluble components of the synthetase reaction mixtures. Our data show that the observed decreases in enzyme activity dylatc kinase activities in the soluble cell fractions. However, in are among the possible consequences of growth inhibition in the allowing only 2 hr for the inhibitor to act, the effect observed on tumor. the transferase was an unexplained stimulation rather than an inhibition. We have also provided some evidence that the inhibition of Materials and Methods growth precedes the inhibition of deoxyribonucleic acid nucleo ENZYME PREPARATION.Fortner hamster plasmacytoma tidyl transferase activity. ("sensitive") (3) and ite cyclophosphamide-resistant subline (12) were used for bilateral s.c. implantation into groups of 6-12 Introduction Golden Syrian hamsters, the animals in each experiment being uniform with respect to commercial subline, sex, and approxi Previous studies in this laboratory have shown that several mate age. On the 12th-14th postimplant day the animals were alkylating agents inhibited the in vivo synthesis of DNA by divided into 2 subgroups, to receive daily i.p.
    [Show full text]
  • On-Demand Synthesis of Phosphoramidites
    ARTICLE https://doi.org/10.1038/s41467-021-22945-z OPEN On-demand synthesis of phosphoramidites Alexander F. Sandahl1, Thuy J. D. Nguyen1, Rikke A. Hansen1, Martin B. Johansen 1, Troels Skrydstrup 1,2 & ✉ Kurt V. Gothelf 1,2 Automated chemical synthesis of oligonucleotides is of fundamental importance for the production of primers for the polymerase chain reaction (PCR), for oligonucleotide-based drugs, and for numerous other medical and biotechnological applications. The highly opti- mised automised chemical oligonucleotide synthesis relies upon phosphoramidites as the 1234567890():,; phosphate precursors and one of the drawbacks of this technology is the poor bench stability of phosphoramidites. Here, we report on the development of an on-demand flow synthesis of phosphoramidites from their corresponding alcohols, which is accomplished with short reaction times, near-quantitative yields and without the need of purification before being submitted directly to automated oligonucleotide synthesis. Sterically hindered as well as redox unstable phosphoramidites are synthesised using this methodology and the sub- sequent couplings are near-quantitative for all substrates. The vision for this technology is direct integration into DNA synthesisers thereby omitting manual synthesis and storage of phosphoramidites. 1 Interdisciplinary Nanoscience Center, iNANO, Aarhus University, Aarhus C, Denmark. 2 Department of Chemistry, Aarhus University, Aarhus C, Denmark. ✉ email: [email protected] NATURE COMMUNICATIONS | (2021) 12:2760 | https://doi.org/10.1038/s41467-021-22945-z | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22945-z ynthetic oligonucleotides are essential for a range of dif- includetheuseofmechanochemistry11 or the use of P(V) chemistry Sferent areas and millions of oligonucleotides are synthesized to form the internucleosidic P–Obond12,13.
    [Show full text]
  • Structure and Function Of
    8/5/2019 DNA and RNA The Code of Life The Human Genome Project Gene Expression Genetic code The alphabet of the genetic code contains Genes are DNA sequences that encode proteins (the gene product) only four letters (A,T,G,C). Gene expression refers to the process A number of experiments confirmed that the whereby the information contained in genes genetic code is written in 3-letter words, each begins to have effects in the cell. of which codes for particular amino acid. DNA encodes and transmits the genetic A nucleic acid word (3 nucleotide letters) is information passed down from parents to offspring. referred to as a codon. 1 8/5/2019 Nucleic acids Nucleotides Principle information molecule in the Nucleotides are the unit structure of cell. nucleic acids. Nucleotides composed of 3 All the genetic codes are carried out on components: the nucleic acids. Nitrogenous base (A, C, G, T or U) Pentose sugar Nucleic acid is a linear polymer of Phosphate nucleotides Nucleotides Nitrogenous bases There are four nitrogen bases making up four different nucleotides. There are 2 types: Purines(pyoo r-een): Adenine A Two ring structure Purines Adenine (A) and Guanine (G) Guanine G Pyrimidines(pahy-rim-i-deen,): N base Single ring structure Cytosine (C) and Thymine (T) or Uracil (U). Thymine T Pyrimidines Cytosine C 2 8/5/2019 A NUCLEOTIDE Nucleotide bases 1. Phosphate Group 2.3. 5Nitrogen-Carbon BaseSugar 1. Phosphate Group 2. 5-Carbon Sugar (Dexoyribose or Ribose) 3. (Dexoyribose or Ribose) 1. 3. Nitrogen Base 2. 3. Nucleotides, too O 1.
    [Show full text]
  • Genetic Variation in Phosphodiesterase (PDE) 7B in Chronic Lymphocytic Leukemia: Overview of Genetic Variants of Cyclic Nucleotide Pdes in Human Disease
    Journal of Human Genetics (2011) 56, 676–681 & 2011 The Japan Society of Human Genetics All rights reserved 1434-5161/11 $32.00 www.nature.com/jhg ORIGINAL ARTICLE Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease Ana M Peiro´ 1,2, Chih-Min Tang1, Fiona Murray1,3, Lingzhi Zhang1, Loren M Brown1, Daisy Chou1, Laura Rassenti4, Thomas A Kipps3,4 and Paul A Insel1,3,4 Expression of cyclic adenosine monophosphate-specific phosphodiesterase 7B (PDE7B) mRNA is increased in patients with chronic lymphocytic leukemia (CLL), thus suggesting that variation may occur in the PDE7B gene in CLL. As genetic variation in other PDE family members has been shown to associate with numerous clinical disorders (reviewed in this manuscript), we sought to identify single-nucleotide polymorphisms (SNPs) in the PDE7B gene promoter and coding region of 93 control subjects and 154 CLL patients. We found that the PDE7B gene has a 5¢ non-coding region SNP À347C4T that occurs with similar frequency in CLL patients (1.9%) and controls (2.7%). Tested in vitro, À347C4T has less promoter activity than a wild-type construct. The low frequency of this 5¢ untranslated region variant indicates that it does not explain the higher PDE7B expression in patients with CLL but it has the potential to influence other settings that involve a role for PDE7B. Journal of Human Genetics (2011) 56, 676–681; doi:10.1038/jhg.2011.80; published online 28 July 2011 Keywords: cAMP; chronic lymphocytic
    [Show full text]